Australia, Aug. 26 -- Terns Pharmaceuticals Inc., owns the trademark (2528171) for 'TERNS' till March 6, 2035.
Status: registered:
Registered/protected
Classes: 5 [Pharmaceutical preparations, namely, small-molecule drugs; Pharmaceutical and biologic preparations for use in the treatment of oncology-related diseases and disorders; Pharmaceutical and biologic preparations for use in the treatment of metabolic-related diseases and disorders; Pharmaceutical and biologic preparations for use in the treatment of endocrine-related diseases and disorders; Pharmaceutical and biologic preparations for use in the treatment of diabetes and obesity-related diseases and disorders; Peptides for pharmaceutical purposes], 42 [Pharmaceutical and biologic ...